Eczema Trial Testing Topical Medication

Adolescents and adults aged 12 years and older with a history of eczema (atopic dermatitis) for at least 6 months, may qualify to participate. Individuals must have mild to moderate disease, involving at least 2% of their body surface area. Disease must be stable for the 4 weeks prior to screening, with no significant flares in atopic dermatitis.

Participants will receive investigational cream (active study drug) or placebo during the treatment period. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation will last about 8 weeks and involve about 5 visits to the study centre.

Learn more about
Atopic Dermatitis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more